Network-based study for identifying potentialbiomarkers for oral cancer diagnosis

سال انتشار: 1402
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 60

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CGC01_286

تاریخ نمایه سازی: 29 آبان 1402

چکیده مقاله:

Introduction: Oral cancer is the sixth most prevalent cancerworldwide. Until now, the molecular causes and genetic factorabnormalities are unclear. this study, analyzed submitted microarraydata with bioinformatic online tools to evaluate hubgenes and their potential in the prediction of the occurrence andrecurrence of oral cancer.Methods: Three microarray datasets including GSE۷۴۳۵۰,GSE۳۷۹۹۱ and GSE۳۱۰۵۶ were extracted from GEO datasetsin NCBI. In each dataset, differentially expressed genes (DEG)with p-value < ۰.۰۵ and logFc ≥ ± ۱.۵ were extracted. commonDEGs between the three datasets were identified by VennDiagrampackage using the R program. Gene ontology (GO) andthe Reactome enrichment analysis were done with the Enrichrtool. PPI network visualized by STRING database and hubgenes selected by the betweenness, degree and Maximal CliqueCentrality (MCC) algorithms in Cystoscope software via cytohubbaplugin. Selected hub genes validated by GEPIA onlineserver, performing overall survival (OS) and disease-free survival(DFS) analysis.Results: Reactome analysis shows that common DEGs are associatedwith the Assembly of Collagen Fibrils, Collagen Formationand degradation. GO term shows the biological processand molecular function of common DEGs in collagen-activatedtyrosine kinase receptor signaling pathway, lipid oxidation andCXCR۳/R chemokine receptor binding. By using Cytoscape wechoose ۱۰ top hub genes using ۳ different algorithms. Analysisof hub genes with GEPIA confirmed the main role of SMPX,IDO۱, PLAU, SPP۱, MMP۱ in oral cancer.Conclusion: Through Integrated bioinformatic and systems biologystudies, we proposed ۵ genes with the potential as diagnosticand or monitoring biomarkers in oral cancer.

کلیدواژه ها:

نویسندگان

Razieh azadian

Department of Clinical Biochemistry, School of Pharmacy andPharmaceutical Sciences, Isfahan University of Medical Sciences Isfahan, Iran

farzaneh yazdanimoghaddam

Department of Clinical Biochemistry, School of medical sciences,Shahid Beheshti University of Medical Sciences, Tehran, Iran